Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 213
Gene Symbol: ALB
ALB
0.350 AlteredExpression disease BEFREE We collected data from health care evaluations on progression to moderate PBC (abnormal level of bilirubin or albumin) or advanced-stage PBC (abnormal level of both). 31419573 2020
Entrez Id: 213
Gene Symbol: ALB
ALB
0.350 Biomarker disease BEFREE Compared with the group with PBC alone, the median hemoglobin and albumin values in the PBC-SLE group at the time of diagnosis of PBC were lower (both P < 0.05). 31807995 2020
Entrez Id: 6672
Gene Symbol: SP100
SP100
0.100 Biomarker disease BEFREE Methods Serum of 184 Belgian SSc patients with a known SSc-antibody profile, was analyzed for PBC-Ab (antimitochondrial antibodies [AMA], anti-Gp210, anti-Sp100 and anti-PML) using indirect immunofluorescence (IIF) analysis on human epithelioma-2000 (HEp-2000) cells (ANA-IIF, Immunoconcepts) and liver-kidney-stomach tissue sections (IIF-LKS) (Menarini), and a line immunoblot (LB) (EuroImmun). 31714880 2020
Entrez Id: 23225
Gene Symbol: NUP210
NUP210
0.070 Biomarker disease BEFREE Methods Serum of 184 Belgian SSc patients with a known SSc-antibody profile, was analyzed for PBC-Ab (antimitochondrial antibodies [AMA], anti-Gp210, anti-Sp100 and anti-PML) using indirect immunofluorescence (IIF) analysis on human epithelioma-2000 (HEp-2000) cells (ANA-IIF, Immunoconcepts) and liver-kidney-stomach tissue sections (IIF-LKS) (Menarini), and a line immunoblot (LB) (EuroImmun). 31714880 2020
Entrez Id: 9965
Gene Symbol: FGF19
FGF19
0.050 Biomarker disease BEFREE In addition, serum FGF19 was remarkably increased in treatment-naïve PBC and decreased after UDCA. 30900136 2020
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.040 Biomarker disease BEFREE After treatment, the group with PBC alone showed lower alanine aminotransferase and glutamyltransferase values and aspartate aminotransferase/platelet ratio indices at the final visit (all P < 0.05). 31807995 2020
Entrez Id: 80150
Gene Symbol: ASRGL1
ASRGL1
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 27295
Gene Symbol: PDLIM3
PDLIM3
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 55226
Gene Symbol: NAT10
NAT10
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 8600
Gene Symbol: TNFSF11
TNFSF11
0.030 Biomarker disease BEFREE However, the accurate role of RANK/RANKL axis in PBC remains unclear. 31377883 2020
Entrez Id: 250
Gene Symbol: ALPP
ALPP
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 26033
Gene Symbol: ATRNL1
ATRNL1
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 10850
Gene Symbol: CCL27
CCL27
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 470
Gene Symbol: ATHS
ATHS
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 6590
Gene Symbol: SLPI
SLPI
0.030 Biomarker disease BEFREE There was no relevant association between the presence of PBC-Ab and ALP or GGT elevation at t0 nor at t3. 31714880 2020
Entrez Id: 1131
Gene Symbol: CHRM3
CHRM3
0.010 GeneticVariation disease BEFREE CHRM3 single-nucleotide polymorphism rs4620530 might confer an increased genetic risk for the development of PBC. 31747477 2020
Entrez Id: 8792
Gene Symbol: TNFRSF11A
TNFRSF11A
0.010 AlteredExpression disease BEFREE The overall hepatic RANK expression was associated with disease severity and biochemical response in PBC patients. 31377883 2020
Entrez Id: 9966
Gene Symbol: TNFSF15
TNFSF15
0.480 GeneticVariation disease GWASCAT POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33. 30643196 2019
Entrez Id: 9966
Gene Symbol: TNFSF15
TNFSF15
0.480 Biomarker disease BEFREE Furthermore, significantly increased TL1A had been detected in liver tissues and mononuclear cells of patients with primary biliary cirrhosis (PBC). 30906791 2019
Entrez Id: 6775
Gene Symbol: STAT4
STAT4
0.470 Biomarker disease BEFREE Immunogenetic studies have identified polymorphisms of the IL-12/STAT4 pathway as being associated with PBC. 31803181 2019
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4
0.390 Biomarker disease CTD_human The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor. 30682444 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.350 Biomarker disease BEFREE Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis. 31430975 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.350 Biomarker disease BEFREE Multivariate analysis identified lower albumin, higher eosinophil count, and etiology of PBC as independent factors associated with severe pruritus (≥5 points of NRS). 31651244 2019
Entrez Id: 941
Gene Symbol: CD80
CD80
0.330 GeneticVariation disease BEFREE This is the first study to demonstrate that POGLUT1 and not CD80 is the effector gene regulated by the primary functional SNP rs2293370, and that increased expression of POGLUT1 might be involved in the pathogenesis of PBC. 30643196 2019
Entrez Id: 941
Gene Symbol: CD80
CD80
0.330 Biomarker disease BEFREE Because activated T cells target the intrahepatic bile ducts in PBC and pre-clinical models suggested that blocking CD80/CD86 with CTLA-4 Ig might have therapeutic benefit in PBC, we performed an open-label trial to determine if CTLA-4 Ig (abatacept) is safe and potentially efficacious in PBC patients with an incomplete response to UDCA. 31027870 2019